FMT
TPTX

First Mercantile Trust’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

First Mercantile Trust’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$73K Sell
1,096
-45
-4% -$3.21K 0.01% 728
2021
Q2 		$89K Sell
1,141
-79
-6% -$5.84K 0.01% 720
2021
Q1 		$115K Sell
1,220
-144
-11% -$17.1K 0.01% 639
2020
Q4 		$166K Buy
1,364
+334
+32% +$36.6K 0.02% 507
2020
Q3 		$116K Sell
1,030
-710
-41% -$49.5K 0.01% 626
2020
Q2 		$112K Buy
+1,740
New +$100K 0.01% 624

Other funds holding TPTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Mercantile Trust's TPTX Position: Q3 2021 in Review

First Mercantile Trust reduced its Turning Point Therapeutics, Inc. Common Stock (TPTX) stake by 3.9% in Q3 2021, selling an estimated $3.21K and leaving 1,096 shares worth $73K. The position accounts for 0.01% of the portfolio, ranked #728.

First Mercantile Trust first reported a position in TPTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $166K in Q4 2020. 190 funds tracked by Wall St. Rank hold TPTX as of Q3 2021.

  • First Mercantile Trust held 1,096 shares of Turning Point Therapeutics, Inc. Common Stock worth $73K as of Q3 2021.
  • First Mercantile Trust sold 45 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $3.21K.
  • Turning Point Therapeutics, Inc. Common Stock made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #728 holding.
  • First Mercantile Trust first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 6 quarters since.
  • First Mercantile Trust's Turning Point Therapeutics, Inc. Common Stock position peaked at $166K in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.